Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 51 - 60 of 81 |
Associate Director, Biostatistics
Cambridge, Massachusetts
Associate Director, Biostatistics Overview: The Associate Director, Biostatistics is responsible for statistical activities in support of clinical trials, including contributing to trial designs, authoring statistical sections of protocols,...
24d
Cambridge, Massachusetts
Legal Director, R&D and Regulatory The Legal Director, R&D and Regulatory will serve as a trusted advisor providing expert legal counsel and strategic guidance across Alnylam's Research & Early Development (ReDev), Regulatory, Global Patien...
24d
Associate Director, Computational Genomics and Informatics
Cambridge, Massachusetts
Overview The Alnylam Human Genetics (AHG) team is looking for an Associate Director to lead our Computational Genomics and Informatics capability through direct, hands-on technical contributions and strategic guidance. The successful candid...
24d
Cambridge, Massachusetts
Senior Clinical Data Manager The Sr. CDM will lead and contribute to data management activities in support of Alnylam studies across all stages of clinical drug development. This position reports to the Director, Clinical Data Management. S...
24d
Associate Director, Statistical Programming
Cambridge, Massachusetts
The Associate Director, Statistical Programming is responsible for statistical programming activities in support of clinical trials including technical and project leadership overseeing the quality and timely delivery of all statistical pro...
24d
Principal Statistical Programmer
Cambridge, Massachusetts
Principal Statistical Programmer The Principal Statistical Programmer will provide expert-level hands-on principal programming support and technical leadership to develop, maintain, validate and run SAS computer programs that access, visual...
24d
Director, Clinical Research-CNS
Cambridge, Massachusetts
Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer, with flexibility and confidence to work across diseases within the neurology therapeutic area. This role includes the opportunity to provide clinical leade...
24d
Director, Global Process Owner, Procure to Pay
Cambridge, Massachusetts
Director, Global Process Owner P2P Position Summary: The Director, Global Process Owner - P2P will play a key leadership role, in defining and driving end-to-end optimal process design efforts across the Procurement Operations (Req to PO), ...
24d
Principal Associate Scientist, Target Validation for Nucleic Acid Therapeutics
Cambridge, Massachusetts
Overview: The Research Department at Alnylam is seeking an experienced Principal Associate Scientist to join an interdisciplinary team dedicated to broaden our oligonucleotide platform and extrahepatic siRNA delivery through in vitro and in...
24d
Director, Regulatory Affairs (U.S. Advertising and Promotion)
Cambridge, Massachusetts
Overview The Director, Regulatory Affairs for U.S. Advertising and Promotion (USAP) will provide strategic regulatory advice to internal stakeholders regarding tactics and communications related to Alnylam's marketed products, investigation...
24d